Paper208462
Treatment with levamisole of recurrent herpes genitalis.
Chang TW and 1 other. Antimicrob Agents Chemother, 1978. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Treatment with levamisole of recurrent herpes genitalis. Papers, record 208462. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/208462
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genital Diseases, Female | Major topic |
| Genital Diseases, Male | Major topic |
| Herpesviridae Infections | Major topic |
| Levamisole | Major topic |
| Adult | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Drug Evaluation | |
| Female | |
| Humans | |
| Male | |
| Recurrence |
Source PubMed
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 212971 | Correlation of clinical and virus-specific immune responses following levamisole therapy of recurrent herpes progenitalis. | Ann N Y Acad Sci | 1977 | https://conductscience.org/library/papers/212971 | PubMed |
| 2 | 191524 | Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis. | J Immunol | 1977 | https://conductscience.org/library/papers/191524 | PubMed |
| 3 | 142150 | Levamisole in the modulation of the immune response: the current experimental and clinical state. | J Reticuloendothel Soc | 1977 | https://conductscience.org/library/papers/142150 | PubMed |
| 4 | 4407116 | Letter: Levamisole for recurrent herpes labialis. | N Engl J Med | 1974 | https://conductscience.org/library/papers/4407116 | PubMed |
| 5 | 1082545 | Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease. | N Engl J Med | 1976 | https://conductscience.org/library/papers/1082545 | PubMed |
| 6 | 4611586 | Letter: Treatment of recurrent aphthous stomatitis and herpes with levamisole. | Br Med J | 1974 | https://conductscience.org/library/papers/4611586 | PubMed |
| 7 | 165245 | Cellular immune responses to Herpes simplex virus type 1 in recurrent herpes labialis: in vitro blastogenesis and cytotoxicity to infected cell line. | J Infect Dis | 1975 | https://conductscience.org/library/papers/165245 | PubMed |
| 8 | 4359402 | Cell-mediated immunity to herpes simplex virus in man. | J Infect Dis | 1974 | https://conductscience.org/library/papers/4359402 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7020907 | Genital herpes simplex. | Can Med Assoc J | 1981 | https://conductscience.org/library/papers/7020907 | PubMed |
| 92398 | Antiviral agents: action and clinical use. | Drugs | 1979 | https://conductscience.org/library/papers/92398 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/208462
GET https://conductscience.org/api/papers/v1/208462/authors